BAX Stock Analysis: Buy, Sell, or Hold?
BAX - Baxter International Inc.
$26.13
0.20 (0.77%)
â˛
5d:
-0.8%
30d:
-2.32%
90d:
+39.14%
WAIT
LOW Confidence
Analysis Updated: Aug 28, 2026 12:00 AM ET
Earnings: Jul 30, 2026
0d
Get Alerted When BAX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
âšī¸ NEUTRAL: BAX is fairly priced but lacks strong directional signals. At 9.7% expected growth, valuation appears stretched. Wait for clearer setup or better entry on dips.
âšī¸ NEUTRAL: BAX is fairly priced but lacks strong directional signals. At 9.7% expected growth, valuation appears stretched. Wait for clearer setup or better entry on dips.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$4.22
Based on -23.9% avg growth
INTRINSIC VALUE TODAY
$2.62
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 9.7x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: BAX is currently trading at $26.13, which is considered fair relative to its 30-day fair value range of $23.80 to $27.70. From a valuation perspective, the stock is trading at a premium (Forward PE: 12.8) compared to its historical average (9.7). At these levels, the market is pricing in 9.7% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, BAX is in a strong uptrend. The price is currently testing key support at $25.75. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: BAX scores 35/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, BAX is in a strong uptrend. The price is currently testing key support at $25.75. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: BAX scores 35/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$23.80 -
$27.70
Company Quality Score
40/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
44.3%
Protect Your Profits
Holding BAX? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- NEUTRAL: Price in fair range
- BEARISH: Weak technical setup (35/100)
- BULLISH: High volume confirmation
- NEUTRAL: Near Wall St target ($28.73)
- NEUTRAL: Trading at premium valuation - market expects 9.7% growth which is achievable
- WARNING: Composite score 40/100 in the bottom quintile â this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$23.80 -
$27.70
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$25.75
Resistance Level
$26.78
Current Trend
Strong Uptrend
Technical data as of
Aug 28, 2026
Fundamental Context
Forward P/E (Next Year Est.)
12.83
Wall Street Target
$28.73
(+9.9%)
Revenue Growth (YoY)
5.3%
Earnings Growth (YoY)
36.8%
Profit Margin
-9.3%
Valuation Premium vs History
+9.7% premium
PE vs Historical
12.8 vs 9.7
STRETCHED
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+9.7%
(market-implied from PE analysis)
1-Year Target
$28.66
(+10%)
2-Year Target
$31.45
(+20%)
3-Year Target
$34.50
(+32%)
3-Yr Target (if PE normalizes)
(PE: 13â10)
PE COMPRESSION
$26.08
(0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 20.1, Growth: -51.8%)
$40.24
(+54%)
Base:
(SPY PE: 12.8, Growth: -51.8%)
$25.73
(-2%)
Bear:
(PE: 9.7, Growth: -51.8%)
$19.45
(-26%)
Share & Embed Analysis
Last updated: August 30, 2026 3:39 AM ET
Data refreshes hourly during market hours. Next update: 4:39 AM
Data refreshes hourly during market hours. Next update: 4:39 AM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is BAX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Instruments & Supplies Stocks
Top-rated stocks in Medical Instruments & Supplies by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ISRG
Intuitive Surgical Inc |
BUY
33 analysts |
$478 | 43 HOLD |
|
ALC
Alcon AG |
STRONG BUY
27 analysts |
$85 | 39 SELL |
|
RGEN
Repligen Corporation |
STRONG BUY
19 analysts |
$186 | 36 SELL |
|
ALGN
Align Technology Inc |
BUY
18 analysts |
$209 | 50 HOLD |
|
RMD
ResMed Inc |
BUY
19 analysts |
$246 | 38 SELL |
Advanced BAX Option Strategies
Professional options setups generated by AI based on today's BAX price and gamma walls.
